Literature DB >> 19878773

Chapter 5: Nuclear CLU (nCLU) and the fate of the cell.

Saverio Bettuzzi1, Federica Rizzi.   

Abstract

The possible biological role played by Clusterin (CLU) has been puzzling researchers for a long time since its first discovery and characterization. CLU has been often described as an "enigmatic" gene, a clear indication that too many aspects of this issue have been obscure or difficult to interpret for long. The good news is that this is certainly no longer true. Since the beginning, CLU was believed to play important roles in nearly all most important biological phenomena. The diversity, sometime the contradictions, of its biological action is now likely explained by the existence of different protein products all generated by the same single copy CLU gene. The relatively recent discovery that CLU can be retained inside the cell and targeted to many intracellular sites and organelles, including the nucleus, provided us a very different view from that solely deriving from its possible role in the outer cellular environment. In particular, nuclear localization of CLU (nCLU) was found to trigger cell death in many systems. In this chapter, a critical review of previous work will enable us to reinterpret old data and observations in the attempt to progressively unravelling the CLU "enigma" by considering its localization inside and outside the cell. The final picture would supposedly reconciliate different or alternative hypothesis. Starting with an "historical" approach demonstrating that nCLU was right under our eyes since the beginning, up to the more recent contributions we will describe which stimuli would inhibit secretion and maturation of CLU leading at least one protein product to target the nucleus and kill the cell. A better understanding of this complex issue is not an easy work, considering the thoughtfulness in reviewing the existing literature and the known controversial reports. We hope that the information contained in this article will be useful for the reader to enlighten this field.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878773     DOI: 10.1016/S0065-230X(09)04005-6

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  8 in total

1.  Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel.

Authors:  Mohamed Kamel Hassan; Hidemichi Watari; Lane Christenson; Saverio Bettuzzi; Noriaki Sakuragi
Journal:  Tumour Biol       Date:  2011-07-15

2.  Time-dependent decrease of clusterin as a potential cerebrospinal fluid biomarker for drug-resistant epilepsy.

Authors:  Weihua Yu; Dan Chen; Zhihua Wang; Chunlei Zhou; Jing Luo; Yali Xu; Lan Shen; Huan Yin; Shuxin Tao; Zheng Xiao; Fei Xiao; Yang Lü; Xuefeng Wang
Journal:  J Mol Neurosci       Date:  2014-02-02       Impact factor: 3.444

3.  Presence, localization, and origin of clusterin in normal human spermatozoa.

Authors:  Zhijian Han; Zengjun Wang; Gong Cheng; Bianjiang Liu; Pengchao Li; Jie Li; Wei Wang; Changjun Yin; Wei Zhang
Journal:  J Assist Reprod Genet       Date:  2012-05-03       Impact factor: 3.412

4.  pVHL mediates K63-linked ubiquitination of nCLU.

Authors:  Jing Xue; Dan-Dan Lv; Shi Jiao; Wenting Zhao; Xuebing Li; Heng Sun; Bing Yan; Li Fan; Rong-Gui Hu; Jing Fang
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

5.  Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.

Authors:  Hans Prochnow; Rene Gollan; Philipp Rohne; Matthias Hassemer; Claudia Koch-Brandt; Markus Baiersdörfer
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

6.  Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies.

Authors:  Jianzhong Zhang; Chenkui Miao; Aiming Xu; Kai Zhao; Zhiqiang Qin; Xiao Li; Chao Liang; Yibo Hua; Wei Chen; Chao Zhang; Yiyang Liu; Shifeng Su; Zengjun Wang; Bianjiang Liu
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

7.  Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.

Authors:  Yuan Zhou; Ikuo Hayashi; Jacky Wong; Katherine Tugusheva; John J Renger; Celina Zerbinatti
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

8.  Transcription Factors Expressed in Mouse Cochlear Inner and Outer Hair Cells.

Authors:  Yi Li; Huizhan Liu; Cody L Barta; Paul D Judge; Lidong Zhao; Weiping J Zhang; Shusheng Gong; Kirk W Beisel; David Z Z He
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.